US Stock MarketDetailed Quotes

TSBX Turnstone Biologics

Watchlist

0.757
-0.034-4.29%

Close Aug 23 16:00 ET

0.762
+0.004+0.57%

Post 20:01 ET

17.51MMarket Cap-234P/E (TTM)

Turnstone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-8.40%-15.93M

-1.69%-17.46M

6.91%-66.15M

20.52%-15.5M

-56.39%-18.79M

36.36%-14.69M

-4.35%-17.17M

-55.74%-71.06M

-19.51M

-12.01M

Net income from continuing operations

0.91%-21.3M

-28,966.18%-19.63M

-79.02%-55.2M

-20.36%-16.45M

-7.23%-17.32M

-285.34%-21.5M

100.54%68K

-192.68%-30.83M

---13.67M

---16.15M

Operating gains losses

----

47.37%-20K

--324K

--0

--338K

--24K

---38K

----

Depreciation and amortization

-31.78%498K

-28.21%509K

-28.27%2.8M

-44.39%659K

-34.76%700K

-21.67%730K

-0.28%709K

180.65%3.9M

--1.19M

--1.07M

Other non cash items

-180.19%-594K

-208.98%-791K

-2,001.02%-2.06M

-292.98%-951K

-1,900.00%-640K

-416.42%-212K

-334.86%-256K

-108.42%-98K

---242K

---32K

Change In working capital

-11.15%4.38M

107.12%1.37M

69.08%-17.92M

102.23%211K

-5.43%-3.8M

112.67%4.93M

-222.78%-19.26M

32.41%-57.97M

---9.48M

---3.61M

-Change in receivables

--0

-95.43%194K

523.94%8.53M

100.54%23K

-97.20%33K

1,656.43%4.23M

396.49%4.25M

14.92%-2.01M

---4.29M

--1.18M

-Change in prepaid assets

52.73%1.12M

243.75%115K

316.24%426K

231.39%2.72M

-179.93%-2.95M

256.41%732K

94.05%-80K

92.62%-197K

---2.07M

--3.69M

-Change in payables and accrued expense

693.78%3.19M

125.64%676K

-207.13%-4.52M

-204.24%-1.52M

69.06%-762K

6,600.00%402K

-452.83%-2.64M

-179.65%-1.47M

--1.46M

---2.46M

-Change in other current assets

129.90%125K

336.81%431K

-373.72%-1.5M

-152.21%-1M

-84.79%103K

---418K

---182K

--548K

--1.92M

--677K

-Change in other current liabilities

-194.44%-53K

96.62%-44K

10.37%-1.56M

98.27%-6K

74.53%-231K

94.75%-18K

-842.03%-1.3M

-175.83%-1.74M

---347K

---907K

-Change in other working capital

----

63.64%-19.31M

--0

-297.08%-19.31M

35.20%-53.1M

---6.16M

---5.78M

Cash from discontinued investing activities

Operating cash flow

-8.40%-15.93M

-1.69%-17.46M

6.91%-66.15M

20.52%-15.5M

-56.39%-18.79M

36.36%-14.69M

-4.35%-17.17M

-55.74%-71.06M

---19.51M

---12.01M

Investing cash flow

Cash flow from continuing investing activities

536.67%18.94M

-14.58%14.1M

-88.14%-28.09M

-191.47%-5.31M

-146.46%-42.26M

203.80%2.98M

2,398.05%16.5M

-346.00%-14.93M

5.8M

-17.15M

Net PPE purchase and sale

-70.21%-80K

80.80%-144K

84.58%-797K

366.67%272K

88.21%-272K

97.81%-47K

-22.35%-750K

-51.79%-5.17M

---102K

---2.31M

Net investment purchase and sale

529.42%19.02M

-17.46%14.24M

-179.61%-27.3M

-194.49%-5.58M

-182.96%-41.99M

520.31%3.02M

16,528.57%17.25M

-16,931.03%-9.76M

--5.9M

---14.84M

Cash from discontinued investing activities

Investing cash flow

536.67%18.94M

-14.58%14.1M

-88.14%-28.09M

-191.47%-5.31M

-146.46%-42.26M

203.80%2.98M

2,398.05%16.5M

-346.00%-14.93M

--5.8M

---17.15M

Financing cash flow

Cash flow from continuing financing activities

81.95%-48K

3,000.83%77.05M

-3,480.00%-169K

2,885.34%78.3M

-290.00%-266K

-8,250.00%-815K

-103.32%-2.66M

-2.81M

Net common stock issuance

----

--77.84M

---179K

----

--0

----

Proceeds from stock option exercised by employees

1,366.67%44K

--0

-33.12%105K

100.00%10K

350.00%9K

-97.86%3K

730.00%83K

-53.69%157K

--5K

--2K

Net other financing activities

----

68.08%-898K

--0

--269K

---269K

---898K

---2.81M

--0

----

Cash from discontinued financing activities

Financing cash flow

81.95%-48K

--0

3,000.83%77.05M

-3,480.00%-169K

2,885.34%78.3M

-290.00%-266K

-8,250.00%-815K

-103.32%-2.66M

--5K

---2.81M

Net cash flow

Beginning cash position

-56.74%14.55M

-48.98%17.91M

-71.63%35.11M

-20.33%38.89M

-73.21%21.65M

-68.45%33.63M

-71.63%35.11M

33.39%123.76M

--48.82M

--80.79M

Current changes in cash

124.77%2.97M

-126.60%-3.37M

80.60%-17.2M

-53.09%-20.98M

153.94%17.25M

53.58%-11.98M

91.35%-1.49M

-386.18%-88.65M

---13.7M

---31.97M

End cash Position

-19.08%17.52M

-56.74%14.55M

-48.98%17.91M

-20.33%38.89M

-73.21%21.65M

-68.45%33.63M

-71.63%35.11M

--35.11M

--48.82M

Free cash flow

-8.30%-16.03M

2.47%-17.6M

11.58%-67.4M

20.94%-15.5M

-32.99%-19.05M

41.34%-14.8M

-5.75%-18.05M

-55.46%-76.23M

---19.61M

---14.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-8.40%-15.93M	-1.69%-17.46M	6.91%-66.15M	20.52%-15.5M	-56.39%-18.79M	36.36%-14.69M	-4.35%-17.17M	-55.74%-71.06M	-19.51M	-12.01M
Net income from continuing operations	0.91%-21.3M	-28,966.18%-19.63M	-79.02%-55.2M	-20.36%-16.45M	-7.23%-17.32M	-285.34%-21.5M	100.54%68K	-192.68%-30.83M	---13.67M	---16.15M
Operating gains losses	----	47.37%-20K	--324K	--0	--338K	--24K	---38K	----	----	----
Depreciation and amortization	-31.78%498K	-28.21%509K	-28.27%2.8M	-44.39%659K	-34.76%700K	-21.67%730K	-0.28%709K	180.65%3.9M	--1.19M	--1.07M
Other non cash items	-180.19%-594K	-208.98%-791K	-2,001.02%-2.06M	-292.98%-951K	-1,900.00%-640K	-416.42%-212K	-334.86%-256K	-108.42%-98K	---242K	---32K
Change In working capital	-11.15%4.38M	107.12%1.37M	69.08%-17.92M	102.23%211K	-5.43%-3.8M	112.67%4.93M	-222.78%-19.26M	32.41%-57.97M	---9.48M	---3.61M
-Change in receivables	--0	-95.43%194K	523.94%8.53M	100.54%23K	-97.20%33K	1,656.43%4.23M	396.49%4.25M	14.92%-2.01M	---4.29M	--1.18M
-Change in prepaid assets	52.73%1.12M	243.75%115K	316.24%426K	231.39%2.72M	-179.93%-2.95M	256.41%732K	94.05%-80K	92.62%-197K	---2.07M	--3.69M
-Change in payables and accrued expense	693.78%3.19M	125.64%676K	-207.13%-4.52M	-204.24%-1.52M	69.06%-762K	6,600.00%402K	-452.83%-2.64M	-179.65%-1.47M	--1.46M	---2.46M
-Change in other current assets	129.90%125K	336.81%431K	-373.72%-1.5M	-152.21%-1M	-84.79%103K	---418K	---182K	--548K	--1.92M	--677K
-Change in other current liabilities	-194.44%-53K	96.62%-44K	10.37%-1.56M	98.27%-6K	74.53%-231K	94.75%-18K	-842.03%-1.3M	-175.83%-1.74M	---347K	---907K
-Change in other working capital	----	----	63.64%-19.31M	--0	--0	--0	-297.08%-19.31M	35.20%-53.1M	---6.16M	---5.78M
Cash from discontinued investing activities
Operating cash flow	-8.40%-15.93M	-1.69%-17.46M	6.91%-66.15M	20.52%-15.5M	-56.39%-18.79M	36.36%-14.69M	-4.35%-17.17M	-55.74%-71.06M	---19.51M	---12.01M
Investing cash flow
Cash flow from continuing investing activities	536.67%18.94M	-14.58%14.1M	-88.14%-28.09M	-191.47%-5.31M	-146.46%-42.26M	203.80%2.98M	2,398.05%16.5M	-346.00%-14.93M	5.8M	-17.15M
Net PPE purchase and sale	-70.21%-80K	80.80%-144K	84.58%-797K	366.67%272K	88.21%-272K	97.81%-47K	-22.35%-750K	-51.79%-5.17M	---102K	---2.31M
Net investment purchase and sale	529.42%19.02M	-17.46%14.24M	-179.61%-27.3M	-194.49%-5.58M	-182.96%-41.99M	520.31%3.02M	16,528.57%17.25M	-16,931.03%-9.76M	--5.9M	---14.84M
Cash from discontinued investing activities
Investing cash flow	536.67%18.94M	-14.58%14.1M	-88.14%-28.09M	-191.47%-5.31M	-146.46%-42.26M	203.80%2.98M	2,398.05%16.5M	-346.00%-14.93M	--5.8M	---17.15M
Financing cash flow
Cash flow from continuing financing activities	81.95%-48K	0	3,000.83%77.05M	-3,480.00%-169K	2,885.34%78.3M	-290.00%-266K	-8,250.00%-815K	-103.32%-2.66M	5K	-2.81M
Net common stock issuance	----	----	--77.84M	---179K	----	----	----	--0	--0	----
Proceeds from stock option exercised by employees	1,366.67%44K	--0	-33.12%105K	100.00%10K	350.00%9K	-97.86%3K	730.00%83K	-53.69%157K	--5K	--2K
Net other financing activities	----	----	68.08%-898K	--0	--269K	---269K	---898K	---2.81M	--0	----
Cash from discontinued financing activities
Financing cash flow	81.95%-48K	--0	3,000.83%77.05M	-3,480.00%-169K	2,885.34%78.3M	-290.00%-266K	-8,250.00%-815K	-103.32%-2.66M	--5K	---2.81M
Net cash flow
Beginning cash position	-56.74%14.55M	-48.98%17.91M	-71.63%35.11M	-20.33%38.89M	-73.21%21.65M	-68.45%33.63M	-71.63%35.11M	33.39%123.76M	--48.82M	--80.79M
Current changes in cash	124.77%2.97M	-126.60%-3.37M	80.60%-17.2M	-53.09%-20.98M	153.94%17.25M	53.58%-11.98M	91.35%-1.49M	-386.18%-88.65M	---13.7M	---31.97M
End cash Position	-19.08%17.52M	-56.74%14.55M	-48.98%17.91M	-48.98%17.91M	-20.33%38.89M	-73.21%21.65M	-68.45%33.63M	-71.63%35.11M	--35.11M	--48.82M
Free cash flow	-8.30%-16.03M	2.47%-17.6M	11.58%-67.4M	20.94%-15.5M	-32.99%-19.05M	41.34%-14.8M	-5.75%-18.05M	-55.46%-76.23M	---19.61M	---14.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall